ucsf banner
Helen Diller Family Compr Cancer Ctr
LLOYD E. DAMON, MD

Associate Clinical Professor, Medicine, UCSF

CONTACT

(415) 353-2421 (appts)
(415) 353-2467 (fax)

Box 0324, UCSF; San Francisco, CA 94143-0324

additional websites:

UCSF Physician Referral Directory

EDUCATION

Olivet College, Olivet, Michigan, B.A., 1978, Chemistry/Biology
University of Michigan Medical School, Ann Arbor, M.D., 1982, Medicine
University of California San Francisco, Residency, 1985, Internal Medicine
University of California San Francisco, Fellowship, 1988, Hematology/Oncology

PROFESSIONAL EXPERIENCE

1976-1978

Instructor, Organic Chemistry Laboratory, Olivet College

1988-1989

Clinical Instructor of Medicine, Univ. California, San Francisco

1989-1995

Assistant Clinical Professor of Medicine, Univ. California, San Francisco

1996-present

Associate Clinical Professor of Medicine, Univ. California, San Francisco

1989-Present

Director, Apheresis and Stem cell Collection Unit, University of California, San Francisco

HONORS & AWARDS

1977

Omicron Delta Kappa Leadership Society

1978

Alpha Chi Scholarship Society

1978

Valedictorian, Olivet College

1982

Alpha Omega Alpha Medical Student Honor Society

1982

Graduated "with distinction", Univ. Michigan Medical School

1985

American Cancer Society Clinical Fellowship Award

SELECTED PUBLICATIONS

Damon LE (1982) Effect of relocation on the elderly. Am Fam Phys 26: 144-148.

Damon LE, Cadman EC (1986) Recent advances in combination chemotherapy. Cancer Invest 4:421-444.

Damon L, Adams M, Stricker R, Ries C (1987) Intracranial bleeding during treatment with hydroxyl ethyl starch. N Engl J Med 317:964-965 (letter).

Damon LE, Cadman EC (1988) Metabolic basis for combination chemotherapy. Pharmacol Ther 38:73-127.

Rochlitz CR, Damon LE, Russi MB, Geddes A, Cadman, EC (1988) Cytotoxicity of ketoconazole in malignant cell lines. Cancer Chemother Pharmacol 21:319-322.

Damon LE, Cadman EC, Benz C (1989) Enhancement of 5-fluorouracil antitumor effect by the prior administration of methotrexate. Pharmacol Ther 43:155-185.

Damon LE, Mass R, Linker CA (1989) The association between high-dose cytosine arabinoside neurotoxicity and renal insufficiency. J Clin Oncol 7:1563-1568.

Damon LE, Christensen S, Rochlitz CR, Cadman EC (1989) Sequence-dependent synergistic cytotoxicity between etoposide and fluoropyrimidines. Anticancer Res 9:1761-1768.

Damon LE, Plunkett W, and Linker CA (1991) Plasma and cerebrospinal fluid pharmacokinetics of 1-β-D-arabinofuranosylcytosine and 1-β-D-arabinofuranosyluracil following the repeated intravenous administration of high and intermediate dose 1-β-D-arabinofuranosylcytosine. Cancer Res 51:4141-4145.

Damon LE (1992) Anemias of chronic disease in the aged: diagnosis and treatment. Geriatrics 47:47-57.

Damon LE, Plunkett W, and Linker CA (1992) Plasma and cerebrospinal fluid pharmacokinetics of 1-β-D-arabinofuranosylcytosine and 1-β-D-arabinofuranosyluracil following the repeated intravenous administration of high-and -intermediate-dose 1-β-D-arabinofuranosylcytosine. Cancer Res. 52:3819-3820 (reply to letter to the editor).

Thompson CE, Damon LE, Ries CA, and Linker CA (1992) Thrombotic microangiopathies in the 1980's: clinical features, response to treatment, and the impact of the HIV epidemic. Blood 80:1890-1895.

Linker CA, Ries CA, Damon LE, Rugo HS, and Wolf JL, (1993). Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood. 81:311-318.

Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, and DeMarco T (1993). Cyclosporine induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transpl. 12:440-444.

Small EJ, Venook AP, and Damon LE (1993). Gallium avid thymic hyperplasia in an adult following chemotherapy for Hodgkin's disease: a case report and review of the literature. Cancer 72:905-908.

Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL (1993). Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update. Semin Oncol 20 (Suppl 4): 40-48.

Damon LE, Rugo HS, Ries CA, Linker CA (1994). Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. Leukemia 8:535-541.

Rugo HS, Damon LE, Ries CA, Wolf JL, Linker CA (1994). High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma. Progress Clin Biology Research 389: 505-11.

Lipschutz JH, Miller T, Yen TSB, Vartannian RK, Graber ML, Damon LE, (1995). Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases. Am J Nephrol 15: 431-435.

Damon LE, Rugo HS, Ries CA, Linker CA (1996). Delayed engraftment of 4-hydroperoxyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia. Bone Marrow Transpl 17:93-9.

Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW (1996). The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone marrow transplantation. Endoscopy 28:680-5.

Zander AR, Kruger W, Kroger N, Damon L, Konigmann M, Berdel WE, Gieseking F, Schafer-Eckart K, Mobus V, Frickhofen N, Wandt H, Illiger HJ, Metzner B, Kolbe K, Wormann B, Trumper L, Huber C, Hossfeld DK, Maass H, Jonat W, for the German GABG-4/EH-93-Study (1996). High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. Bone Marrow Transpl 18 (Suppl 1):S24-25.

DeMarco T, Damon LE, Colombe B, Keith F, Chatterjee K, Garovoy M (1997). Successful immunomodulation with intravenous gammaglobulin and cyclophosphamide in an alloimmunized cardiac transplant recipient. J Heart Lung Transpl.16:360-5.

Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA (1997). High-dose Ara-C (HDAC) dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol 15:833-839.

Damon LE (1997). Increasing survival in invasive breast cancer. Cancer Management Today 2:1-5.

Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC Jr, Beer M, Ahmed T (1997). A randomized trial of high vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia. Leukemia 11: 485-489.

Linker CA, Ries CA, Damon LE, Rugo HS, and Wolf JL (1998). Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone Marrow Transpl 22:865-872.

Books and Book Chapters

Rugo HS, Damon LE (1990) Occupational hematology. In Occupational Medicine, Joseph LaDou (ed): Appleton and Lange Medical Publications, East Norwalk, CT. pp 155-169.

Damon LE (1994). Immunohematology. In Manual of Allergy and Immunology, Glenn J. Lawlor Jr., Thomas J. Fischer, Daniel Adelman (eds): Little, Brown and Company, Boston/Toronto. pp 353- 380.

Small EJ and Damon LE (1996) Blood. In Geriatrics, Lonergan ET (ed): Appleton and Lange, Stamford, CT. pp 262-287.

Rugo HS, Damon LE (1997) Occupational hematology. In Occupational & Environmental Medicine, Joseph LaDou (ed): Appleton & Lange, Stamford, CT. pp 204-220.

Ignoffo RJ, Viele CS, Damon LE, Venook A (eds) (1997). Cancer Chemotherapy Pocket Guide. Lippincott-Raven Publishers

2/1/05

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.